Can genetic editing help improve the overall health of people living with type 1 diabetes? The results of a recent study ...

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

CRISPR technology could one day create “designer babies, ” raising major ethical and social inequality concerns.

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $51.81, indicating a -3.5% shift from the ...

The nonexclusive license potentially broadens VedaBio's platform while making it simpler and more cost-effective.